Project Grant R01AG099343
- Federal Grant Award Summary The National Institute on Aging awarded a $676,587 Project Grant to Weill Medical College of Cornell University on February 15, 2026, under the Aging Research program (CFDA 93.866) to conduct a mixed-methods study examining the effectiveness of civil monetary penalties (CMPs) in improving nursing home quality of care. The five-year project, extending through January 31, 2031, will analyze comprehensive datasets spanning 2011-2024 to assess whether CMPs serve as...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Weill Medical College of Cornell University a Project Grant of $212,770.00 (awarded August 15, 2025, with completion by April 30, 2030) under the Aging Research program (CFDA 93.866) to advance research and mentoring initiatives addressing elder mistreatment among persons living with Alzheimer's disease and related dementias (ADRD). The grant supports two primary objectives: mentoring and supporting the next...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $268,650 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded August 15, 2025, with completion scheduled for May 31, 2027. The project, titled "A Calvarial Stem Cell Mediating a New Bone-Brain Axis in Alzheimer's Disease," investigates the role of skeletal stem cells (SSCs) in the calvarium (skull bone) and their influence on Alzheimer's disease...
- Federal Grant Award Summary This $1.42 million Project Grant, awarded September 30, 2025, by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), funds biomedical research at Weill Medical College of Cornell University through June 30, 2030. The award supports investigation into the mechanistic relationship between apolipoprotein E4 (ApoE4), cholesterol 25-hydroxylase (CH25H), and tau-induced neurodegeneration in Alzheimer's disease (AD). The research focuses...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $129,096 to Weill Medical College of Cornell University, effective March 1, 2026, through December 31, 2030, under the Aging Research program (CFDA 93.866). This award supports research and training activities examining the implications of retailer-owned primary care clinics for access to and quality of care among older adults aged 65 and older. The project investigates major pharmacy chain and...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $109,076 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded March 3, 2026, with completion scheduled for September 2, 2029. This research project investigates vulnerable cell populations in aging-induced circadian clock remodeling and disruption through high-throughput single-nucleus ribonucleic acid (RNA) sequencing of flash-frozen tissues. The...
- Federal Project Grant Award Summary The National Institute on Aging awarded Weill Medical College of Cornell University a Project Grant totaling $1,494,457 (awarded September 15, 2025; completion date June 30, 2030) under the Aging Research program (CFDA 93.866) to conduct biomedical research on Complex III-derived Reactive Oxygen Species (ROS) in mitochondrial-nuclear crosstalk related to Alzheimer's disease and related dementias. The research will advance understanding of how disease-linked...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Weill Medical College of Cornell University a Project Grant totaling $466,125.00 on August 1, 2025, under the Aging Research program (CFDA 93.866) to support a two-year research initiative examining aging in the liver, alcohol consumption, and the retinoic acid pathway. The research will be conducted at the institution's New York facility through July 31, 2027. The project investigates how retinoic acid receptor...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant totaling $423,750 to Weill Medical College of Cornell University on August 15, 2025, under the Aging Research program (CFDA 93.866) to investigate the relationship between preoperative biological age and surgical outcomes in older adults. The research will utilize the UK Biobank cohort (n=502,649) to determine the effect of preoperative biological age on one-year postoperative mortality and evaluate...
- Federal Grant Award Summary The National Institute on Aging awarded George Mason University a $1.18 million Project Grant under the Aging Research program (CFDA 93.866) to conduct a comprehensive research study on non-medical supplemental benefits, health service utilization, and health outcomes in Medicare Advantage (MA) plans. The five-year project, awarded February 15, 2026, with completion targeted for January 31, 2031, examines the relationship between MA non-medical supplemental...
Weill Medical College of Cornell University received a $720,523 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded June 15, 2026, with completion scheduled for March 31, 2031. This research initiative will evaluate the impact of Integrated Dual Eligible Special Needs Plans (Integrated D-SNPs) on healthcare utilization, quality of care, mortality outcomes, and chronic disease management among the population of dual eligible individuals with disabilities who qualify for both Medicare and Medicaid coverage. The study addresses a critical evidence gap, as Integrated D-SNP enrollment among this vulnerable population grew 12-fold between 2018 and 2024, yet limited empirical data exists regarding program effectiveness and implementation outcomes. The research will examine how these Medicare Advantage plans—which coordinate Medicare and Medicaid benefits and streamline administrative processes through state Medicaid agency contracts—impact health outcomes for individuals with physical, intellectual, developmental, cognitive, or mental disabilities. This investigation is particularly significant given that dual eligibles with disabilities experience high prevalence of multiple chronic conditions, substantial long-term services and supports needs, and preventable premature mortality rates of 40-60 percent. By generating evidence on Integrated D-SNP performance, outcomes, and operational effectiveness, this project aims to inform policy and practice improvements for better serving this population's complex healthcare and support service needs.Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $720.5k | 6/9/26 |